Allergies News and Research

Latest Allergies News and Research

Study suggests a novel therapeutic target to reverse lung fibrosis

Researchers have reversed lung fibrosis in a mouse model of idiopathic pulmonary fibrosis, or IPF, as reported in a study published in the journal Cell Death and Differentiation.

24 Aug 2021

Researchers create a novel strategy for developing an effective TB vaccine

Innovators at Purdue University and Houston Methodist Research Institute have created a novel strategy for developing an effective vaccine for a widespread form of tuberculosis.

20 Aug 2021

HHS public health and medical experts release joint statement on COVID-19 booster shots for Americans

Today, public health and medical experts from the U.S. Department of Health and Human Services released the following statement on the Administration's plan for COVID-19 booster shots for the American people.

18 Aug 2021

HHS public health and medical experts release statement on plan for COVID-19 booster shots

Today, public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement on the Administration's plan for COVID-19 booster shots for the American people.

18 Aug 2021

Obstructive sleep apnea may affect heart health and increase blood pressure in children

Obstructive sleep apnea, a form of sleep-disordered breathing, is common in children and adolescents and may be associated with elevated blood pressure and changes in heart structure.

18 Aug 2021

Researchers receive $26.5 million NIH grant to pursue a new strategy for curing HIV

Over the last 40 years, HIV has shifted from a deadly and mysterious virus to one that can be controlled with daily drugs. But attempts to completely eliminate the virus from the bodies of people living with HIV, curing them for good, have failed.

17 Aug 2021

Study investigates airborne and fomite transmission of SARS-CoV-2 in Syrian hamsters

National Institutes of Health scientists studying SARS-CoV-2, the virus that causes COVID-19, have defined in Syrian hamsters how different routes of virus exposure are linked to disease severity.

17 Aug 2021

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

Too many "exhausted" T cells left in the wake of aggressive chemotherapy regimens for patients with advanced chronic lymphocytic leukemia (CLL) make it more challenging for chimeric antigen receptor (CAR) T cell therapy to do its job.

16 Aug 2021

‘I don’t want to risk my life for a paycheck’: Immunosuppressed people grapple with returning to work

Elizabeth Groenweghe got a kidney transplant 14 years ago. She now takes several medications to prevent her body from rejecting her transplant organ. But these medications also weaken her immune system, putting her at higher risk of becoming seriously ill if she catches covid-19.

13 Aug 2021

Study finds worsening disparities among states in use of HIV-prevention drugs

States with low initial use of HIV-prevention drugs are continuing to fall behind in usage among people at risk for the disease, a new study finds.

12 Aug 2021

South Australian-developed SARS-CoV-2 vaccine shows promise to prevent COVID-19 lung infection

A South Australian-developed SARS-CoV-19 vaccine is preparing to progress to the final stages of human clinical trials after early animal testing confirmed its safety and effectiveness in preventing COVID-19 lung infection.

12 Aug 2021

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite.

11 Aug 2021

Potential new treatment for mast cell cancers reduces tumor size and prevents organ infiltration

A potential new treatment for mast cell cancers reduces the number of mast cells by "mutating" the messenger RNA (mRNA) before it can deliver instructions for manufacturing the gene responsible for cell proliferation.

10 Aug 2021

Pilot study assesses antibody response to third COVID-19 vaccine dose in kidney transplant recipients

A pilot study has begun to assess the antibody response to a third dose of an authorized COVID-19 mRNA vaccine in kidney transplant recipients who did not respond to two doses of the Moderna or Pfizer-BioNTech COVID-19 vaccine.

10 Aug 2021

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

A new study from Japan, released as a medRxiv* preprint, describes the adverse effects associated with the vaccine. Such data is crucial in delineating the safety and efficacy of this intervention in various age groups.

6 Aug 2021

Investigational treatment improves survival rate of babies lacking thymus

An investigational treatment pioneered by a Duke Health pediatrician resulted in a one-year survival rate of 77% among children born with a rare condition in which they lack an immune system.

4 Aug 2021

Study suggests second Pfizer-BioNTech vaccine shot may not be needed after previous SARS-CoV-2 infection

Researchers in Austria have conducted a study showing that individuals previously infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit a significantly more pronounced antibody response to one dose of Pfizer-BioNTech’s coronavirus disease 2019 (COVID-19) vaccine than previously uninfected individuals.

3 Aug 2021

Allergies News and Research

Latest Allergies News and Research

Study suggests a novel therapeutic target to reverse lung fibrosis

Researchers create a novel strategy for developing an effective TB vaccine

HHS public health and medical experts release joint statement on COVID-19 booster shots for Americans

HHS public health and medical experts release statement on plan for COVID-19 booster shots

Obstructive sleep apnea may affect heart health and increase blood pressure in children

Researchers receive $26.5 million NIH grant to pursue a new strategy for curing HIV

Study investigates airborne and fomite transmission of SARS-CoV-2 in Syrian hamsters

Study identifies mechanism of resistance and presents a much-needed target for advanced leukemias

‘I don’t want to risk my life for a paycheck’: Immunosuppressed people grapple with returning to work

Study finds worsening disparities among states in use of HIV-prevention drugs

South Australian-developed SARS-CoV-2 vaccine shows promise to prevent COVID-19 lung infection

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

Potential new treatment for mast cell cancers reduces tumor size and prevents organ infiltration

Pilot study assesses antibody response to third COVID-19 vaccine dose in kidney transplant recipients

Study reports on COVID-19 vaccine-related adverse events in young Japanese population

Investigational treatment improves survival rate of babies lacking thymus

Study suggests second Pfizer-BioNTech vaccine shot may not be needed after previous SARS-CoV-2 infection

CHOP researchers identify two proteins that could be used for a potential NTHi vaccine

Newly identified genetic mutation causes rare, early onset inflammatory bowel disease

NIH scientists demonstrate efficient aerosol transmission of SARS-CoV-2 in hamsters

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Allergies News and Research

Latest Allergies News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in